tbResList Print — Ara-C Cytosine Arabinoside/Cytarabine

Filters: qv=471, qv2=%, rfv=%

Product

Ara-C Cytosine Arabinoside/Cytarabine
Features: Chemotherapy Drug
Description: <p><b>Cytarabine</b> - Cytosine Arabinoside</p>

<p><b>Recommended Abbreviation:</b> Ara-C, Cytarabine</p>

<p><b>Alternative Names:</b> Cytosine arabinoside, Ara-C</p>

<p><b>Type:</b> Antimetabolite / pyrimidine nucleoside analog / chemotherapy drug</p>

<p><b>Function:</b> Cytarabine is converted intracellularly to its active triphosphate metabolite, ara-CTP, which competes with deoxycytidine triphosphate for incorporation into DNA and inhibits DNA polymerase. This disrupts DNA synthesis and preferentially affects rapidly dividing cells during S phase.</p>

<p><b>Cancer:</b> Established anticancer drug used particularly in acute myeloid leukemia and other hematologic malignancies. Cytarabine induces replication stress, DNA synthesis inhibition, cell-cycle arrest, and apoptosis.</p>

Pathway results for Effect on Cancer / Diseased Cells

Total Targets: 0

Pathway results for Effect on Normal Cells

Total Targets: 0

Research papers

Year Title Authors PMID Link Flag